LifeMD, Inc. (LFMD)
NASDAQ: LFMD · Real-Time Price · USD
5.04
+0.14 (2.86%)
At close: Dec 20, 2024, 4:00 PM
5.18
+0.14 (2.78%)
After-hours: Dec 20, 2024, 6:33 PM EST
LifeMD Revenue
LifeMD had revenue of $53.39M in the quarter ending September 30, 2024, with 38.27% growth. This brings the company's revenue in the last twelve months to $193.06M, up 42.16% year-over-year. In the year 2023, LifeMD had annual revenue of $152.55M with 28.15% growth.
Revenue (ttm)
$193.06M
Revenue Growth
+42.16%
P/S Ratio
1.04
Revenue / Employee
$914,972
Employees
211
Market Cap
218.29M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 152.55M | 33.51M | 28.15% |
Dec 31, 2022 | 119.03M | 26.16M | 28.16% |
Dec 31, 2021 | 92.88M | 55.58M | 149.04% |
Dec 31, 2020 | 37.29M | 24.83M | 199.10% |
Dec 31, 2019 | 12.47M | 4.14M | 49.79% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
biote | 193.06M |
SOPHiA GENETICS | 64.49M |
Profound Medical | 8.98M |
Ocugen | 4.70M |
Precigen | 3.96M |
Cardiff Oncology | 688.00K |
Inhibikase Therapeutics | 1.00 |
LFMD News
- 6 weeks ago - LifeMD, Inc. (LFMD) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - LifeMD Reports Third Quarter 2024 Results - GlobeNewsWire
- 3 months ago - LifeMD® Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock - GlobeNewsWire
- 3 months ago - LifeMD: Selling WorkSimpli Could Be A Catalyst - Seeking Alpha
- 4 months ago - LifeMD to Participate in Three Investor Conferences During September - GlobeNewsWire
- 4 months ago - LifeMD, Inc. (LFMD) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - LifeMD Reports Second Quarter 2024 Results - GlobeNewsWire
- 5 months ago - LifeMD: High Growth GLP-1 Telehealth Play At A Discount - Seeking Alpha